Nov 11 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2022 Sep 30, 2021 Mar 31, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 5.65 5.98 14.10
(-5.5 pct) (+9.2 pct)
Operating loss 346 mln loss 568 mln 160 mln
Recurring loss 324 mln loss 568 mln 190 mln
Net loss 230 mln loss 464 mln 130 mln
EPS loss 61.02 yen loss 122.83 yen 34.38 yen
Ann Div 40.00 yen 40.00 yen
-Q2 div NIL NIL
-Q4 div 40.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T